Genotropin + Genotropin
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Idiopathic Short Stature
Conditions
Idiopathic Short Stature
Trial Timeline
Dec 1, 2006 → Aug 1, 2012
NCT ID
NCT00396097About Genotropin + Genotropin
Genotropin + Genotropin is a phase 3 stage product being developed by Pfizer for Idiopathic Short Stature. The current trial status is completed. This product is registered under clinical trial identifier NCT00396097. Target conditions include Idiopathic Short Stature.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00396097 | Phase 3 | Completed |
Competing Products
20 competing products in Idiopathic Short Stature